Literature DB >> 28798987

Maximization of interventricular conduction time by means of quadripolar leads for cardiac resynchronization therapy.

Giuseppe Stabile1, Valter Bianchi2, Francesco Solimene3, Assunta Iuliano4, Quintino Parisi5, Patrizia Pepi6, Mario Bocchiardo7, Francesco Urraro3, Antonio De Simone8, Roberto Ospizio9, Antonio D'Onofrio2.   

Abstract

PURPOSE: Identifying the left ventricular (LV) site associated with the maximum spontaneous interventricular conduction time (right ventricle (RV)-to-LV interval) has proved to be an effective strategy for optimal LV pacing site selection in cardiac resynchronization therapy (CRT). The aim of our study was to determine whether quadripolar LV lead technology allows RV-to-LV interval maximization.
METHODS: We enrolled 108 patients undergoing implantation of a CRT system using an LV quadripolar lead and 114 patients who received a bipolar lead. On implantation, the RV-to-LV interval was measured for the dipole of the bipolar leads and for each electrode of the LV lead (tip, ring 2, ring 3, ring 4).
RESULTS: In the quadripolar group, the mean RV-to-LV interval ranged from 90 ± 33 ms (tip) to 94 ± 32 ms (R4) (p > 0.05 for all comparisons). In 55 (51%) patients, the RV-to-LV interval was > 80 ms at all electrodes, while in 27 (25%) patients, no electrodes were associated with an RV-to-LV interval > 80 ms. At least one LV pacing electrode was associated with an RV-to-LV interval > 80 ms in 62 (70%) patients with a short (36 mm) inter-electrode distance, and in 19 (95%, p = 0.022) of those with a long distance (50.5 mm). In the bipolar group, the mean RV-to-LV interval was 72 ± 37 ms (p < 0.001 versus quadripolar). The RV-to-LV interval was > 80 ms in 44 (39%) patients (p < 0.001 versus quadripolar leads with both short and long inter-electrode distance).
CONCLUSIONS: Quadripolar leads allow RV-to-LV interval maximization. An optimal RV-to-LV interval seems achievable in the majority of patients, especially if the leads present a long inter-electrode distance.

Entities:  

Keywords:  Cardiac resynchronization therapy; Interventricular electrical delay; Quadripolar leads

Mesh:

Year:  2017        PMID: 28798987     DOI: 10.1007/s10840-017-0279-x

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  11 in total

1.  Performance of Anatomically Designed Quadripolar Left Ventricular Leads: Results from the NAVIGATE X4 Clinical Trial.

Authors:  Suneet Mittal; Devi Nair; Benzy J Padanilam; Allen Ciuffo; Nigel Gupta; Peter Gallagher; Bruce Goldner; Eric F Hammill; Nicolas Wold; Kenneth Stein; Martin Burke
Journal:  J Cardiovasc Electrophysiol       Date:  2016-08-19

2.  The interventricular conduction time is associated with response to cardiac resynchronization therapy: interventricular electrical delay.

Authors:  Antonio D'Onofrio; Gianluca Botto; Massimo Mantica; Concetto La Rosa; Eraldo Occhetta; Roberto Verlato; Giulio Molon; Ernesto Ammendola; Giovanni Q Villani; Maria Grazia Bongiorni; Gian Paolo Gelmini; Carmine Ciardiello; Cosimo D Dicandia
Journal:  Int J Cardiol       Date:  2013-07-30       Impact factor: 4.164

3.  Interlead anatomic and electrical distance predict outcome in CRT patients.

Authors:  Giuseppe Stabile; Antonio D'Onofrio; Patrizia Pepi; Antonio De Simone; Matteo Santamaria; Salvatore Ivan Caico; Antonio Rapacciuolo; Luigi Padeletti; Domenico Pecora; Tiziana Giovannini; Giuseppe Arena; Alfredo Spotti; Assunta Iuliano; Emanuele Bertaglia; Maurizio Malacrida; Giovanni Luca Botto
Journal:  Heart Rhythm       Date:  2015-05-19       Impact factor: 6.343

4.  Left ventricular three-dimensional quadripolar lead acute clinical study: the LILAC study.

Authors:  François Philippon; Lili Liu; Jeffrey Wing-Hong Fung; Jean-Claude Deharo; Frederic Anselme; Peter Paul Delnoy; Harry Crijns; Carlos A Morillo; Andrew D Krahn; Klaus Gutleben; Julien Delumeau; Franck Molin
Journal:  Pacing Clin Electrophysiol       Date:  2015-01-28       Impact factor: 1.976

Review 5.  Geometrical and electrical predictors of cardiac resynchronization therapy response.

Authors:  Giuseppe Stabile; Assunta Iuliano; Vincenzo La Rocca; Francesco Solimene; Roberta Fazio; Antonio De Simone
Journal:  Expert Rev Cardiovasc Ther       Date:  2014-05-22

Review 6.  Avoiding non-responders to cardiac resynchronization therapy: a practical guide.

Authors:  Claude Daubert; Nathalie Behar; Raphaël P Martins; Philippe Mabo; Christophe Leclercq
Journal:  Eur Heart J       Date:  2017-05-14       Impact factor: 29.983

7.  Radiographic left ventricular-right ventricular interlead distance predicts the acute hemodynamic response to cardiac resynchronization therapy.

Authors:  E Kevin Heist; Dali Fan; Theofanie Mela; Daniel Arzola-Castaner; Vivek Y Reddy; Moussa Mansour; Michael H Picard; Jeremy N Ruskin; Jagmeet P Singh
Journal:  Am J Cardiol       Date:  2005-09-01       Impact factor: 2.778

8.  Left ventricular lead electrical delay predicts response to cardiac resynchronization therapy.

Authors:  Jagmeet P Singh; Dali Fan; E Kevin Heist; Chrisfouad R Alabiad; Cynthia Taub; Vivek Reddy; Moussa Mansour; Michael H Picard; Jeremy N Ruskin; Theofanie Mela
Journal:  Heart Rhythm       Date:  2006-08-10       Impact factor: 6.343

9.  The relationship between ventricular electrical delay and left ventricular remodelling with cardiac resynchronization therapy.

Authors:  Michael R Gold; Ulrika Birgersdotter-Green; Jagmeet P Singh; Kenneth A Ellenbogen; Yinghong Yu; Timothy E Meyer; Milan Seth; Patrick J Tchou
Journal:  Eur Heart J       Date:  2011-08-29       Impact factor: 29.983

10.  Multipoint pacing via a quadripolar left-ventricular lead: preliminary results from the Italian registry on multipoint left-ventricular pacing in cardiac resynchronization therapy (IRON-MPP).

Authors:  Giovanni B Forleo; Luca Santini; Massimo Giammaria; Domenico Potenza; Antonio Curnis; Vito Calabrese; Danilo Ricciardi; Carlo D'agostino; Pasquale Notarstefano; Valentina Ribatti; Giovanni Morani; Massimo Mantica; Luigi Di Biase; Emanuele Bertaglia; Leonardo Calò; Francesco Zanon
Journal:  Europace       Date:  2017-07-01       Impact factor: 5.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.